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background:  High on clopidogrel treatment Platelet Reactivity (HPR) has been identified as a risk factor for new ischemic events after an 
acute myocardial infarction (MI). Little is known about variation of HPR over time.
methods:  We used Multiplate®, a whole blood impedance aggregation method, to assess ADP-stimulated platelet reactivity on three 
occasions, 3 and 8 days, and 6 months, after clopidogrel loading, in patients with acute (MI). All patients were treated with dual antiplatelet 
therapy including clopidogrel. A value above 468 AU*min was regarded as HPR.
Results:  We included 77 patients, mean age 77 years, 60 % with STEMI and 74 % men. Abciximab was administered to 45 patients. 
Median aggregometry value was significantly higher day 8 compared to day 3 (281 vs 159 AU*min, p<0.001) but not from day 8 to 6 
months (281 vs 288 AU* min, p=0.67). The proportion of HPR was higher day 8 compared to day 3 (16% vs 8%, p<0.001, but there was 
no significant change from day 8 to 6 months (16% vs 21%, p=0.24). In spite of this a substantial proportion of the patients changed HPR 
status between day 8 and 6 months, 10 % changed from HPR to low platelet reactivity (LPR) 16 % LPR to HPR. (Fig 1) 
conclusion:  In spite of a similar rate of HPR at 8 days and 6 months after loading dose of clopidogrel, more than 1/4 of the patients 
change HPR status from high to low or low to high platelet reactivity. This finding may be important for the value of individual decision 
making based on a single HPR assessment.
